| 000 | 01672 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516212207.0 | ||
| 264 | 0 | _c20150112 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-014-2975-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMotevalli, Azadeh | |
| 245 | 0 | 0 |
_aThe effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cJun 2014 |
||
| 300 |
_a581-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAzacitidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDNA _xgenetics |
| 650 | 0 | 4 |
_aDNA Methylation _xgenetics |
| 650 | 0 | 4 | _aDecitabine |
| 650 | 0 | 4 | _aEpigenesis, Genetic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xpharmacology |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 |
_aMethyltransferases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 | _aShelterin Complex |
| 650 | 0 | 4 |
_aTelomere _xdrug effects |
| 650 | 0 | 4 |
_aTelomere Homeostasis _xdrug effects |
| 650 | 0 | 4 |
_aTelomere-Binding Proteins _xbiosynthesis |
| 700 | 1 | _aYasaei, Hemad | |
| 700 | 1 | _aVirmouni, Sara Anjomani | |
| 700 | 1 | _aSlijepcevic, Predrag | |
| 700 | 1 | _aRoberts, Terry | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 145 _gno. 3 _gp. 581-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-014-2975-x _zAvailable from publisher's website |
| 999 |
_c23805529 _d23805529 |
||